Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and continues to portend poor survival, despite multimodal treatment using surgery and chemoradiotherapy. The addition of tumour-treating fields (TTFields)-an approach in which alternating electrical fields exert biophysical force on charged and polarisable molecules known as dipoles-to standard therapy, has been shown to extend survival for patients with newly diagnosed GBM, recurrent GBM and mesothelioma, leading to the clinical approval of this approach by the FDA. TTFields represent a non-invasive anticancer modality consisting of low-intensity (1-3 V/cm), intermediate-frequency (100-300 kHz), alternating electric fields delivered via cutaneous transducer arrays configured to provide optimal tumour-site coverage.
View Article and Find Full Text PDFWith the recent publication of a new World Health Organization brain tumour classification that reflects increased understanding of glioma tumour genetics, there is a need for radiologists to understand the changes and their implications for patient management. There has also been an increasing trend for adopting earlier, more aggressive surgical approaches to low-grade glioma (LGG) treatment. We will summarize these changes, give some context to the increased role of tumour genetics and discuss the associated implications of their adoption for radiologists.
View Article and Find Full Text PDFBackground. Pediatric chronic pain is considered to be a multidimensional construct that includes biological, psychological, and social components. Methods.
View Article and Find Full Text PDFBackground: Cross-informant variance is often observed in patient self-reports versus parent proxy reports of pediatric chronic pain and disability.
Objective: To assess the relationship and merit of the child versus parent perspective.
Methods: A total of 99 patients (eight to 17 years of age [mean 13.